Drug & supplement interaction

Pancreatic Enzyme Products + Lonafarnib

Lonafarnib brand name: Zokinvy.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Pancreatic Enzyme Products and Lonafarnib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the label for Lonafarnib states a food rule worth keeping to, and the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.

Know someone taking this? Share
Interaction report

Pancreatic Enzyme Products and Lonafarnib

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Lonafarnib and Pancreatic Enzyme Products in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Pancreatic Enzyme Products safety at a glance

Pancreatic Enzyme... overall Use caution Generally well-tolerated when used correctly, but should be guided by a healthcare provider, especially for medical conditions.
Pregnancy Use caution May be used when clearly needed under medical supervision, but discuss with your doctor first.
Breastfeeding Use caution Little data exists, so use only under the guidance of your healthcare provider.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Lonafarnib and Pancreatic Enzyme Products? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Lonafarnib

Interactions in our licensed database are recorded against drug classes, not just single drug names. Lonafarnib is filed under 5 classifications — including cytochrome p450 2c9 (cyp2c9) substrates, cytochrome p450 3a4 (cyp3a4) inhibitors, nephrotoxic drugs. Pancreatic Enzyme Products has documented interactions with 1 drug class — the most serious being acarbose (precose, prandase) (moderate) — and none of Lonafarnib’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

Pancreatic Enzyme Products Does Interact With Other Medications

Pancreatic Enzyme Products has 1 moderate known drug interaction in our database — Lonafarnib isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Pancreatic Enzyme Products

Covers the 2,830 medications we’ve checked against Pancreatic Enzyme Products. Pick one to open its full report.

What to actually watch for

No Interaction Found — But Data Suggests Pancreatic Enzyme Products and Lonafarnib May Share Several of the Same Side Effects

This is not an interaction. Neither one changes how your body handles the other, and nothing here says they react together. What our sources do show is that each has separately been linked to the effects below — so taking both can make those effects more likely to turn up, and harder to pin on one or the other if they do. 2 of them are worth acting on rather than waiting out — marked below.

  • High blood sugar Worth acting on Additional detail

    Pancreatic Enzyme Products

    “Orally, prescription pancreatic enzyme products may cause hypoglycemia or hyperglycemia in some patients. In a double-blind trial of a prescription pancreatic enzyme product compared with placebo in patients with unresectable pancreatic cancer and associated pancreatic duct obstruction, one patient developed diabetes during the study period.”

    Pancreatic Enzyme Products · Natural Medicines adverse-effect record, reported in cancer.

    4 sources cited
    1. 67622. O'Keefe, S. J., Cariem, A. K., and Levy, M. The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis. J Clin Gastroenterol. 2001;32(4):319-323. PubMed
    2. 98676. Whitcomb DC, Bodhani A, Beckmann K, et al. Efficacy and safety of pancrelipase/pancreatin in patients with exocrine pancreatic insufficiency and a medical history of diabetes mellitus. Pancreas. 2016;45(5):679-86. PubMed
    3. 98677. Ramesh H, Reddy N, Bhatia S, et al. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis. Pancre PubMed
    4. 67708. Bruno, M. J., Haverkort, E. B., Tijssen, G. P., Tytgat, G. N., and van Leeuwen, D. J. Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. Gut 1998;42(1):92-96. PubMed

    Lonafarnib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lonafarnib. Read the label on DailyMed ›

  • A low white blood cell count Worth acting on Additional detail

    Pancreatic Enzyme Products

    “Orally, severe neutropenia has been reported with a pancreatic enzyme product. In one case report, a 61-year-old patient taking a prescription pancreatic enzyme product for chronic pancreatitis developed agranulocytosis that persisted despite a trial of filgrastim. Upon discontinuation of the pancreatic enzyme product, marked improvement in neutropenia occurred within 7 days, with full resolution within 6 weeks.”

    Pancreatic Enzyme Products · Natural Medicines adverse-effect record, reported in pancreatitis.

    1 source cited
    1. 107411. Amoateng R, Hardman B, Liu C, Austin S. Rare case of pancrelipase therapy-induced neutropaenia. BMJ Case Rep 2021;14(3):e241799. PubMed

    Lonafarnib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lonafarnib. Read the label on DailyMed ›

  • Bloating or gas / Constipation / Stomach pain / Diarrhea / Vomiting Additional detail

    Pancreatic Enzyme Products

    “Orally, prescription pancreatic enzyme products can cause abdominal pain, constipation, diarrhea, dry mouth, irritation of the skin around the mouth and anus, flatulence, nausea, steatorrhea, and vomiting. However, these symptoms can be controlled by following prescription dosing recommendations.”

    Pancreatic Enzyme Products · Natural Medicines adverse-effect record, reported in constipation.

    6 sources cited
    1. 67617. Bragelmann, R., Armbrecht, U., Rosemeyer, D., Schneider, B., Zilly, W., and Stockbrugger, R. W. The effect of pancreatic enzyme supplementation in patients with steatorrhoea after total gastrectomy. Eur.J Gastroenterol.Hepatol. 1999;11(3):231-237. PubMed
    2. 67618. Halm, U., Loser, C., Lohr, M., Katschinski, M., and Mossner, J. A double-blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency. Aliment.Pharmacol.Ther. PubMed
    3. 67645. Andersen, H. O., Hjelt, K., Waever, E., and Overgaard, K. The age-related incidence of meconium ileus equivalent in a cystic fibrosis population: the impact of high-energy intake. J Pediatr Gastroenterol.Nutr 1990;11(3):356-360. DOI
    4. 67648. Ramo, O. J., Puolakkainen, P. A., Seppala, K., and Schroder, T. M. Self-administration of enzyme substitution in the treatment of exocrine pancreatic insufficiency. Scand.J Gastroenterol. 1989;24(6):688-692. PubMed
    5. 67651. Aparisi, L., Rodrigo, J. M., Serra, M. A., Del Olmo, J., Bisquert, M., and Raga, F. [Efficacy of a new microencapsulated pancreatin versus a conventional preparation, in the treatment of steatorrhea of pancreatic origin]. Rev.Esp.Enferm.Apar.Dig. 1989;76
    6. 67653. Ansaldi-Balocco, N., Santini, B., and Sarchi, C. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages DOI

    Lonafarnib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lonafarnib. Read the label on DailyMed ›

  • A stuffy or runny nose Additional detail

    Pancreatic Enzyme Products

    “Topically, exposure to pancreatic enzyme product powder is irritating to the respiratory tract. Hypersensitivity reactions such as sneezing have been reported (15). Inhalation of dust containing pancreatic enzyme products has been associated with allergic rhinitis, asthma, bronchospasm, and pulmonary hypersensitivity reactions.”

    Pancreatic Enzyme Products · Natural Medicines adverse-effect record, reported in allergic rhinitis (hay fever).

    4 sources cited
    1. 15. McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
    2. 11768. Bergner A, Bergner RK. Pulmonary hypersensitivity associated with pancreatin powder exposure. Pediatrics 1975;55:814-7. DOI
    3. 11769. Wiessmann KJ, Baur X. Occupational lung disease following long-term inhalation of pancreatic extracts. Eur J Respir Dis 1985;66:13-20.
    4. 67641. Shin, S. Y., Hur, G. Y., Ye, Y. M., and Park, H. S. A case of occupational rhinitis caused by porcine pancreatic extract developing into occupational asthma. J Korean Med Sci. 2008;23(2):347-349. PubMed

    Lonafarnib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lonafarnib. Read the label on DailyMed ›

  • A skin rash Additional detail

    Pancreatic Enzyme Products

    “Orally, rash or skin conditions have been reported rarely in individuals taking prescription pancreatic enzyme products. A pruritic rash occurred in one patient taking a prescription pancreatic enzyme product in one clinical trial; this event was considered by the investigators to be possibly related to treatment.”

    Pancreatic Enzyme Products · Natural Medicines adverse-effect record, reported in erythema.

    4 sources cited
    1. 67709. Miyoshi, H. and Kanzaki, T. Drug eruption (erythema multiforme type) due to a digestive enzyme drug. J Dermatol. 1998;25(1):28-31. PubMed
    2. 98667. Seiler CM, Izbicki J, Varga-Szabó L, et al. Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a
    3. 98675. Lee SK, Kim MS, Lee UH. Acute generalized exanthematous pustulosis induced by a digestive enzyme drug, Festal(®). Clin Exp Dermatol. 2018;43(3):321-323.
    4. 15. McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.

    Lonafarnib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lonafarnib. Read the label on DailyMed ›

  • Headache Additional detail

    Pancreatic Enzyme Products

    “Orally, headache and dizziness have been reported rarely in individuals taking prescription pancreatic enzyme products.”

    Pancreatic Enzyme Products · Natural Medicines adverse-effect record, reported in cluster headache.

    3 sources cited
    1. 67618. Halm, U., Loser, C., Lohr, M., Katschinski, M., and Mossner, J. A double-blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency. Aliment.Pharmacol.Ther. PubMed
    2. 98667. Seiler CM, Izbicki J, Varga-Szabó L, et al. Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a
    3. 99120. Trapnell BC, Maguiness K, Graff GR, Boyd D, Beckmann K, Caras S. Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis. J Cyst Fibros. 2009;8(6):370-7. PubMed

    Lonafarnib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lonafarnib. Read the label on DailyMed ›

Showing the 10 most notable of 11 shared effects — ranked by how unusual each one is, not just whether both lists mention it.

Reported for Pancreatic Enzyme Products but not commonly for Lonafarnib: mouth irritation or sores, an allergic reaction, pancreatitis and wheezing.

Effects for Lonafarnib come from the ADVERSE REACTIONS section of its FDA label; effects for Pancreatic Enzyme Products come from the Natural Medicines adverse-effect record, quoted above. Wording is matched across sources by our own clinical vocabulary, so treat this as a prompt to pay attention, not a diagnosis.

How to take them

Some Lonafarnib Products Have a Food Rule — Pancreatic Enzyme Products Should Not Break It

At least one FDA label for a product containing Lonafarnib says to take it with food. If you take Pancreatic Enzyme Products on an empty stomach out of habit, keep them separate — and take Lonafarnib with a meal where the label says to.

This may not be true of your version. Food instructions belong to the product, not the ingredient: two Lonafarnib products can carry different directions, and extended-release forms often differ from immediate-release ones. The label we read is quoted below — check the directions on your own box or bottle, or ask your pharmacist, for how to take the exact product you were given.

If a dose is missed, take the dose as soon as possible with food, up to 8 hours prior to the next scheduled dose.

From the Dosage and Administration section of the FDA label we read for Lonafarnib — where that label names a specific product, the instruction is that product's. Read the label on DailyMed ›

A food rule is not an interaction — it is about how much of the medicine you absorb. The directions that came with your own product, and your pharmacist, outrank anything on this page.

Everything else you take

See Every Supplement That Interacts With Lonafarnib

This page covers Pancreatic Enzyme Products only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Lonafarnib page lists 160 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Asarabacca (major), Grapefruit (major), Siberian Cocklebur (major) and St. John's Wort (major).

By severity: 5 major · 115 moderate · 40 minor.

From our pharmacist’s overview on the Lonafarnib page

“If you or your child takes lonafarnib (Zokinvy) for progeria, treat supplements with real caution. Most of the 160 flagged ingredients cross paths with the CYP3A4 enzyme, the same one that handles lonafarnib, so the traffic runs both ways.”

Reviewed by 2 · Jul 18, 2026

Open the Lonafarnib interaction page

One more smart check

Taking Pancreatic Enzyme Products as Part of a Dietary Supplement Product? Check It for Interactions

We hold 26 real supplement products containing Pancreatic Enzyme Products, each one broken down to its full ingredient list — and combination products often carry several ingredients besides Pancreatic Enzyme Products. Even though Pancreatic Enzyme Products itself has no known interaction with Lonafarnib, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where Pancreatic Enzyme Products and Lonafarnib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Pancreatic Enzyme Products
Steady interest

#1,304 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Lonafarnib
Steady interest

#2,277 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Pancreatic Enzyme Products reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 27, 2026. The Pancreatic Enzyme Products and Lonafarnib records this page draws on were last updated July 10, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Pancreatic Enzyme Products

What is Pancreatic Enzyme Products?

  • Trouble digesting food (exocrine pancreatic insufficiency)
  • Cystic fibrosis
  • Chronic pancreatitis
  • After pancreas surgery or removal
  • Pancreatic cancer-related digestion problems
  • Bloating and gas (over-the-counter products)

Pancreatic enzyme products supply the digestive enzymes (lipase, protease, and amylase) that some people cannot make enough of, helping them break down and absorb food. Prescription versions are well-proven and FDA-approved for conditions like cystic fibrosis and chronic pancreatitis, while over-the-counter 'pancreatin' supplements are not as tightly regulated. Always work with a doctor or pharmacist to get the right product and dose.

Pancreatic tissue (usually from pigs or cattle) · Capsules, delayed-release (enteric-coated) capsules, tablets, and powders

An interaction check asks whether these two react with each other — it does not ask whether Pancreatic Enzyme Products is a good idea for someone in your situation. Here is what our Pancreatic Enzyme Products record says about it on its own.

Pancreatic Enzyme Products: dosing

There is no single dose that fits everyone. Prescription pancreatic enzymes are dosed based on the amount of lipase units per meal, the person's body weight (especially in children), and how severe the enzyme shortage is. Your doctor will adjust the dose based on your symptoms, weight, and nutrition.In general, these products are taken with meals and snacks, often with the dose split so part is taken at the start of the meal. Enteric-coated capsules should usually be swallowed whole and not crushed or chewed.

From our Pancreatic Enzyme Products monograph — the full record covers uses, side effects and every documented interaction.

Read the full Pancreatic Enzyme Products monograph & all interactions
Medication

About Lonafarnib

What Is Lonafarnib Used For?

Brand name: Zokinvy

Zokinvy (lonafarnib) is approved for patients 12 months of age and older who have a body surface area of 0.39 m² or above. It is used to reduce the risk of mortality in Hutchinson-Gilford Progeria Syndrome (HGPS) — a rare, severe premature-aging disorder.

Zokinvy is also used to treat processing-deficient Progeroid Laminopathies — a related group of rare genetic conditions — specifically those caused by a heterozygous LMNA mutation with progerin-like protein buildup, or by homozygous or compound heterozygous ZMPSTE24 mutations. It is not indicated for other Progeroid Syndromes or processing-proficient Progeroid Laminopathies.

Most-Reported Side Effects for Lonafarnib

From FAERS, the FDA’s public side-effect reporting system (77 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Diarrhea 16 reports
Vomiting 12 reports
Headache 4 reports
Abdominal pain upper 3 reports
Asthenia 3 reports
See full Lonafarnib drug information
Keep checking

Other Drugs & Pancreatic Enzyme Products

Browse every other medication we’ve checked against Pancreatic Enzyme Products — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
1Moderate
0Minor
2,828No known interaction
Moderate

1 interaction

No interaction 2,828 drugs checked — show the list
Evidence & sources

Pancreatic Enzyme Products References

The 40 references that drive our Pancreatic Enzyme Products monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Martindale W. Martindale the Extra Pharmacopoeia. Pharmaceutical Press, 1999.
  2. McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
  3. Smyth RL, van Velzen D, Smyth AR, et al. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994;343:85-6. PubMed
  4. Bergner A, Bergner RK. Pulmonary hypersensitivity associated with pancreatin powder exposure. Pediatrics 1975;55:814-7. DOI
  5. Wiessmann KJ, Baur X. Occupational lung disease following long-term inhalation of pancreatic extracts. Eur J Respir Dis 1985;66:13-20.
  6. Bragelmann, R., Armbrecht, U., Rosemeyer, D., Schneider, B., Zilly, W., and Stockbrugger, R. W. The effect of pancreatic enzyme supplementation in patients with steatorrhoea after total gastrectomy. Eur.J Gastroenterol.Hepatol. 1999;11(3):231-237. PubMed
  7. Halm, U., Loser, C., Lohr, M., Katschinski, M., and Mossner, J. A double-blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency. Aliment.Pharmacol.Ther. PubMed
  8. O'Keefe, S. J., Cariem, A. K., and Levy, M. The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis. J Clin Gastroenterol. 2001;32(4):319-323. PubMed
  9. Shin, S. Y., Hur, G. Y., Ye, Y. M., and Park, H. S. A case of occupational rhinitis caused by porcine pancreatic extract developing into occupational asthma. J Korean Med Sci. 2008;23(2):347-349. PubMed
  10. Andersen, H. O., Hjelt, K., Waever, E., and Overgaard, K. The age-related incidence of meconium ileus equivalent in a cystic fibrosis population: the impact of high-energy intake. J Pediatr Gastroenterol.Nutr 1990;11(3):356-360. DOI
  11. Ramo, O. J., Puolakkainen, P. A., Seppala, K., and Schroder, T. M. Self-administration of enzyme substitution in the treatment of exocrine pancreatic insufficiency. Scand.J Gastroenterol. 1989;24(6):688-692. PubMed
  12. Aparisi, L., Rodrigo, J. M., Serra, M. A., Del Olmo, J., Bisquert, M., and Raga, F. [Efficacy of a new microencapsulated pancreatin versus a conventional preparation, in the treatment of steatorrhea of pancreatic origin]. Rev.Esp.Enferm.Apar.Dig. 1989;76
  13. Ansaldi-Balocco, N., Santini, B., and Sarchi, C. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages DOI
  14. Beverley, D. W., Kelleher, J., Macdonald, A., Littlewood, J. M., Robinson, T., and Walters, M. P. Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis.Child 1987;62(6):564-568. PubMed
  15. Silber, W. Pankreoflat in benign diseases of the oesophagus: a blind therapeutic trial. S.Afr.Med J 7-7-1973;47(26):1137-1138.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Pancreatic Enzyme Products and Lonafarnib Together: Common Questions

Is it safe to take Pancreatic Enzyme Products with Lonafarnib?
We do not list a known interaction between Pancreatic Enzyme Products and Lonafarnib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Do Pancreatic Enzyme Products and Lonafarnib have any of the same side effects?
Yes — our sources link each of them separately to 10 of the same effects. That is not an interaction: neither changes how your body handles the other. It does mean that if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
Should I take Pancreatic Enzyme Products and Lonafarnib at the same time of day?
At least one FDA label for a product containing Lonafarnib says to take it with food. If you take Pancreatic Enzyme Products on an empty stomach out of habit, keep them separate and take Lonafarnib with a meal where the label says to. Food instructions belong to the product rather than the ingredient — two Lonafarnib products can differ — so check the directions on your own box. This is about absorption, not an interaction.
How was the Pancreatic Enzyme Products and Lonafarnib combination checked?
Interactions in our licensed database are recorded against drug classes. Lonafarnib is filed under 5 classifications, and Pancreatic Enzyme Products has documented interactions with 1 drug class — none of Lonafarnib's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does Pancreatic Enzyme Products interact with any other medications?
Yes. Pancreatic Enzyme Products has 1 documented drug interaction in our database — Lonafarnib is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Lonafarnib interact with any supplements?
Yes. Lonafarnib has documented interactions with 160 supplements in our database — Pancreatic Enzyme Products is not one of them. The Lonafarnib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Lonafarnib and Pancreatic Enzyme Products?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.